Cart
sales@molnova.com
NSC5844
CAS No. 140926-75-6
NSC5844( NSC5844 | NSC-5844 | NSC 5844 | RE640 )
Catalog No. M17281 CAS No. 140926-75-6
NSC5844 (RE640) is a bisquinoline compound with C-C chemokine receptor type 1 (CCR1)-agonistic activities.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 42 | Get Quote |
|
| 10MG | 80 | Get Quote |
|
| 25MG | 132 | Get Quote |
|
| 50MG | 196 | Get Quote |
|
| 100MG | 291 | Get Quote |
|
| 200MG | 435 | Get Quote |
|
| 500MG | 698 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameNSC5844
-
NoteResearch use only, not for human use.
-
Brief DescriptionNSC5844 (RE640) is a bisquinoline compound with C-C chemokine receptor type 1 (CCR1)-agonistic activities.
-
DescriptionNSC5844, also known as RE640, is a bisquinoline compound with C-C chemokine receptor type 1 (CCR1)-agonistic properties.
-
In VitroNSC5844 (Compound 10) is a 4-aminoquinoline derivative, and has antitumor activity with GI50s of 7.35 ± 0.10 μM and 14.80 ± 0.35 μM against MDA-MB-468 and MCF-7 cells, respectively. NSC5844 (Compound 1) is cytotoxic to P. falciparum, inhibits the growth of chloroquine-sensitive (D-6) and -resistant (W-2) clones of P. falciparum, with IC50s of 17 and 27 nM, respectively.
-
In Vivo——
-
SynonymsNSC5844 | NSC-5844 | NSC 5844 | RE640
-
PathwayPI3K/Akt/mTOR signaling
-
TargetPI3K
-
RecptorCCR1
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number140926-75-6
-
Formula Weight383.27
-
Molecular FormulaC20H16Cl2N4
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 1 mg/mL (2.61 mM)
-
SMILESc1cc2c(ccnc2cc1Cl)NCCNc1c2ccc(cc2ncc1)Cl
-
Chemical NameN,N'-bis(7-chloroquinolin-4-yl)ethane-1,2-diamine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zhang H, et al. Biomed PharmacOthers. 2008 Feb;62(2):65-9.
molnova catalog
related products
-
Palosuran hydrochlor...
Palosuran is a new potent and specific antagonist of the human UT receptor with an IC50 of 3.6±0.2 nM.
-
PI-3065
A potent inhibitor of PI3K p110δ with IC50/Ki values of 5/1.5 nM respectively.
-
Dactolisib
A potent, dual ATP-competitive pan-class I PI3K and mTOR inhibitor for p110α/γ/δ/β and mTOR(p70S6K) with IC50 of 4 nM /5 nM /7 nM /75 nM /6 nM, respectively.
